2025 Poster Index
Presenter Name
Poster Title
Yasir AbdelgadirPrecision in Nephrology Coding: Evaluating the Specificity of ICD-10 Diagnoses in Mayo Clinic Billing Data
Yasir AbdelgadirAssessing Public Awareness of Hyponatremia and Its Associated Conditions from 2004-2024
Tongwa B. Aka, MDAcute Renal Failure and Secondary Membranous Nephropathy in a Patient with Secondary Syphilis: A Case Report
Tongwa B. Aka, MDBRASH Syndrome Triggered by GLP-1 Agonist-Induced Acute Kidney Injury: A Case Report
María Alejandra Arroyo Vélez, MDAssociation between Ringer’s Lactate solution and hyperkalemia in patients with reduced kidney function.
Sebastián LópezSeven Days to Hemodialysis: Acute Renal Failure in a Patient with Undiagnosed Systemic Lupus Erythematosus (SLE)—A Case Report
Alex Barnes, PA-CReversal of Severe Metabolic Abnormalities of a Ureterosigmoidostomy After Percutaneous Nephrostomy Tube Placement
Tyler BenningComparative Analysis of Glomerular Filtration Rate Estimation Methods in Pediatric Hematology/Oncology Patients: A Retrospective Study
Joshua Daum, MD, MSAttack of the clonal populations: a case of alternative complement pathway activation and recurrent PGNMID treated with daratumumab
Lauren DwyerImplications of Proteinuria Remission on Estimated Glomerular Filtration Rate (eGFR) Trajectory in Patients With IgA Nephropathy (IgAN) in PROTECT
Abdullah Jalal MDA Rare Case of concomitant renal parenchymal infiltration of Lymphoplasmacytic Lymphoma with Secondary Membranous Nephropathy
Leanna Ritchie, MD Severe Rhabdomyolysis Induced by Statin Use and Florida Heat and Exacerbated by Extensive Diarrhea
Rachel Jenkins, MDBurnt-Out Kidneys
Vanessa KrajcoA Phase 3 Trial of Pegcetacoplan for C3G and IC-MPGN in Adult and Adolescents
Poemlarp Mekraksakit, MDAll in one; a case with multiple renal findings associated with multiple myeloma
Kelsey Mirkovic, PhDAvacopan for Granulomatosis With Polyangiitis and Microscopic Polyangiitis in a Real-World Setting
Desmond Murphy, PharmD, RPhKidney Function and Isolated Kidney Transplant Outcomes in Primary Hyperoxaluria Type 1 Treated with Long-term Lumasiran
Danielle O’DonnellResults From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
Sally I. Othman MD, MPHComplex Presentation of IgA Nephropathy and FSGS Leading to Severe Nephrotic Syndrome in a 23-Year-Old Female with Morbid Obesity
Yasir QaziEffect of Sparsentan a Novel Dual Endothelin Angiotensin II Receptor Antagonist (DEARA) on Proteinuria in Kidney Transplant
Elvana Rista, MD, PhDValvular Calcification in Dialysis Patients: Key Predictors Identified in a Single-Center Analysis
Alexandra Perez Aldosterone synthase inhibitor vicadrostat (BI 690517) ± empagliflozin in a CKD phase II trial: Effects on albuminuria and SBP in patients by hypertension status at baseline
John Roth, MDResolution of AKI following Intensive Dialysis for Oxalate Nephropathy
Michael Roth, BDWhen It Rains, It Perfs: A Case of a Perforated Duodenal Ulcer in the Context of Acute Tubular Necrosis and Urosepsis
Mohammad Salman SheikhA Multicenter Survey on Artificial Intelligence in Nephrology: Perspectives from Mayo Clinic Fellows
Mohammad Salman SheikhA Rare Case of HHV-8 Negative Multicentric Castleman Disease: Diagnostic Complexities and Therapeutic Insights
Dr Abhishek VadherParadoxical Hyperkalemia in Bartter Syndrome: A Case Report of Severe Resistant Hyperkalemia Requiring Hemodialysis
Samiddhi Weerasiri, MDFeeling Stressed? Diagnostic Intricacies of Central Adrenal Insufficiency
Yee, Andy, DOCrystalline Nephropathy: a hidden complication of Bariatric surgery
Anaelle C Zimmowitch, MDA Case of IgA Vasculitis-Associated Nephritis

Thank you for your interest in submitting an abstract for consideration of a poster at the Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2025 in Orlando, Florida. Please complete the fields below and click submit at the end of the form. You should receive a confirmation e-mail after you click submit. NOTE: You must be logged in to submit.

Accepted abstract recipients will be chosen from all abstracts received by Friday, December 27, 2024 submission deadline. Notification of acceptance can occur within 1-2 weeks of submission prior to this deadline and no later than 1 week after this deadline.

Application:

  • All fields are required, omitting this information may lead to rejection of your abstract. Abstract presenters are required to attend the full meeting.
  • Additional authors cannot be added after the abstract has been submitted.
  • NO graphs or references allowed - text only please.
  • Submission of an abstract does not automatically register you for the course.

Abstracts can be submitted in the following formats:

  • Research Abstracts: All types of nephrology-related research are eligible for submission and should address scientific questions, detail clinical observations, or contain preliminary scientific data.  Also research into  systems-based practice innovation or improvements will be reviewed for acceptance. 
  • Clinical Cases:  These may include challenging clinical cases encountered in practice (ie., case reports) of those encountered in clinical practice. Case reports must include uniqueness of the case, clinical findings presented, outcomes documented, and "take-away" lessons (teaching points).

Abstract Eligibility:
Original abstracts that either have or have not been presented at other meetings will be considered for the conference.  Abstracts based upon published papers will also be considered. 

Number of Entries:
A participant may be the primary author on no more than two abstracts, however, he or she may be a contributing author on any number of abstracts.

Notification of Results:
Accepted abstracts will be notified by email. All primary authors will be notified by email no later than 2 weeks following their submission, if their submission has been selected for the poster session and details regarding poster set-up will follow.  Accepted abstract recipients must still register for the meeting to attend. 

Inquiries:
For further information, contact Iwona Bukato at flacmeabstracts@mayo.edu.